Single EU patent court delayed ‘until 2016 or beyond’ as jurisdiction amended
This article was originally published in Clinica
Executive Summary
The European Commission is planning to update the legislation on court jurisdiction and the recognition of judgments in order to allow the future Unified Patent Court to enter into force as soon as possible. But the upshot of this enabling measure is that the court is unlikely to be operational until 2016 or beyond, as the national and internecine politics play out.
You may also be interested in...
Changes To EU Pharma Reform: More Questions Than Answers?
In the first of a series of articles on the future direction of the EU pharmaceutical reform proposals, the Pink Sheet looks at the new uncertainties created for the drug industry after the European Parliament voted through a series of amendments in the area of regulatory data protection.
Post-Brexit UK Risks Being ‘Left Out In The Cold’ As EU Coordinates Action On Shortages
The UK is not alone in experiencing drug shortages, as data from across Europe show, but its departure from the EU makes it more difficult to respond to supply chain pressures, according to new research.
EU Countries Offered Funding To Contribute to African Regulatory Strengthening
Training projects are intended to strengthen the African regulatory environment, boost the capacity of the African Medicines Agency, facilitate regulatory reliance, and increase joint new drug assessments.